tumor lysis syndrome

Acronym	Definition
TLS	Times Literary Supplement
TLS	Thread Local Storage
TLS	The Last Samurai (movie)
TLS	Target Level of Safety (aviation)
TLS	Top Level Specification
TLS	Target LAN Server
TLS	Taiwan Light Source
TLS	Toulouse, France - Blagnac (Airport Code)
TLS	Teclas Locos Salvatruchos (Maryland; Mara Salvatrucha clique)
TLS	Tactical Laser System (Ace Combat; video game)
TLS	Terminology and Lexical Semantics (International Workshop)
TLS	Thermal Laser Stimulation
TLS	Time Line Sheet
TLS	Transmitter Location Systems, LLC
TLS	Thang Long Securities (Vietnam)
TLS	Transformed Least Squares
TLS	Turbo Lycoming Sabre (aircraft engine)
TLS	Table of shared Locked States
TLS	Training-Leader Development-Soldier Support
TLS	Two-Layer Spreading
TLS	Tactical Landing Strip
TLS	Translocated in Liposarcoma-associated protein
TLS	Trimmed Leaf Size (printing/publishing)
TLS	Theater Logistics Station
TLS	Transmission-Line Stamp
TLS	Transfer-Line Spill
TLS	Trans-cowl Locking System (Pratt & Whitney)
TLS	Transmit Level Sensor
TLS	Time-Line Summary
TLS	Trzy Literowy Skrót (Polish: three letter acronym)
TLS	Triple Lead Sheath
TLS	Tactical Landing System
TLS	Text Library System (Financial Planning Consultants, Inc.)
TLS	Transport LAN Service (US West)
TLS	Transport Layer Security
TLS	Tekniska Litteratursällskapet (Swedish Society for Technical Documentation)
TLS	Thesaurus & Linguistic Integrated System (IBM)
TLS	Transaction Layer Security
TLS	Transaction Level Security
TLS	Tumor Lysis Syndrome
TLS	Total Least Squares
TLS	The Last Supper
TLS	Typed Letter Signed (autographs)
TLS	Transperfect Legal Solutions (New York, NY)
TLS	Tactical Logistics Systems
TLS	Trinity Lutheran School
TLS	Tons of Liquid Steel
TLS	Transponder Landing System
TLS	Through Life Support
TLS	Third Level Support
TLS	The Logan School (Denver, Colorado)
TLS	Transparent LAN Service
TLS	Terrestrial Laser Scanning (earth science)
TLS	Triple Link Suspension
TLS	Top Level School (USMC)
TLS	Timor Leste (East Timor ISO code)
TLS	The Learning Station (band; Melbourne, FL)
TLS	Total Logistics Support (Navy)
TLS	The Living Statues (band)
TLS	Tunable Laser Source
TLS	Total Logistics Support

References in periodicals archive	?		Acronyms browser	?		Full browser	?
Risks associated with VELCADE therapy include new or worsening peripheral neuropathy, hypotension observed throughout therapy, cardiac and pulmonary disorders, gastrointestinal adverse events, thrombocytopenia, neutropenia and tumor lysis syndrome. MILLENNIUM/HARVARD MEDICAL SCHOOL SIGN CANCER RESEARCH PACT by Biotech Business Risks associated with VELCADE therapy include new or worsening peripheral neuropathy, hypotension observed throughout therapy, cardiac and pulmonary disorders, gastrointestinal adverse events, thrombocytopenia, neutropenia and tumor lysis syndrome. Millennium and Harvard Medical School Sign Cooperative Cancer Biology ... by BIOTECH Patent News 4,5) Approved by the Food and Drug Administration in 1997 for use in patients with low-grade or follicular, CD20-positive, B cell non-Hodgkin's lymphoma, rituximab has been linked to an extensive list of reported side effects, including infusion reactions, tumor lysis syndrome, mucocutaneous reactions, hypersensitivity reactions, cardiac arrhythmias, angina, and renal failure. Development of nasal skin necrosis associated with rituximab ... by Constantinides, Minas / Ear, Nose and Throat Journal	TULOB TULP TULPS TULR TULRA TULS TULTW TUM TUMA TUMAS TUMAS-A TUMAV TUMB TUMC TUMCA TUMD tUME TUMF TUMH TUMI TUMJ TUMM TUMOL TUMOM TUMONZ tumor lysis syndrome TUMP TUMRA TUMS TUMSS TUMST TUMT TUMV TUMW TUMY TUN TUNA TUNA-P TUNAC TUNADO TUNAECS TUNAFE TUNCOM TUNE TUNEL TUNES TUNFS TUNG TUNI TUNIP TUNIS	Tumor Culture Conditioning Medium tumor debulking tumor development Tumor Development Time in 50% Tumor Differentially Expressed 1 Tumor Endothelial Marker 1 Tumor Endothelial Marker 7 Tumor Endothelial Marker 8 tumor enhancement tumor enhancement tumor enhancement tumor enhancement tumor enhancement Tumor Gene Database Tumor Growth Delay Time Tumor Growth Factor Section Tumor Growth Inhibition Tumor Growth Inhibition Index Tumor Growth Inhibition Rate Tumor Growth Ratio on the 14th Day tumor identification training for autologous immunocompetent cells tumor immunology tumor immunology tumor immunology tumor immunotherapy tumor immunotherapy tumor immunotherapy tumor implant Tumor Interstitial Fluid Pressure Tumor Involvement of the Pulmonary Vessels tumor lysis syndrome tumor marker tumor marker tumor marker tumor marker tumor marker Tumor Marker Utility Grading System Tumor markers Tumor markers, biological Tumor Microenvironment of Metastasis Tumor Migration Inhibition Factor tumor necrosis tumor necrosis factor tumor necrosis factor tumor necrosis factor tumor necrosis factor tumor necrosis factor tumor necrosis factor tumor necrosis factor (TNF) tumor necrosis factor (TNF) tumor necrosis factor (TNF) Tumor necrosis factor alpha Tumor Necrosis Factor Alpha Induced Protein 1 Tumor Necrosis Factor Alpha Receptor p75 Tumor Necrosis Factor Alpha Receptor-1 Tumor Necrosis Factor Alpha-Induced Protein Tumor Necrosis Factor Alpha-Induced Protein 6 Tumor Necrosis Factor Binding Protein Tumor Necrosis Factor C Receptor Tumor necrosis factor receptor Tumor Necrosis Factor Receptor 1

References in periodicals archive

Acronyms browser

Full browser

Risks associated with VELCADE therapy include new or worsening peripheral neuropathy, hypotension observed throughout therapy, cardiac and pulmonary disorders, gastrointestinal adverse events, thrombocytopenia, neutropenia and tumor lysis syndrome.

MILLENNIUM/HARVARD MEDICAL SCHOOL SIGN CANCER RESEARCH PACT by Biotech Business

Millennium and Harvard Medical School Sign Cooperative Cancer Biology ... by BIOTECH Patent News

4,5) Approved by the Food and Drug Administration in 1997 for use in patients with low-grade or follicular, CD20-positive, B cell non-Hodgkin's lymphoma, rituximab has been linked to an extensive list of reported side effects, including infusion reactions, tumor lysis syndrome, mucocutaneous reactions, hypersensitivity reactions, cardiac arrhythmias, angina, and renal failure.

TLS (redirected from tumor lysis syndrome)

TLS
(redirected from tumor lysis syndrome)